期刊文献+

干扰素γ临床应用新进展 被引量:4

Progress in the clinical application of interferon gamma
原文传递
导出
摘要 干扰素γ(IFN-γ)属于Ⅱ型干扰素,是一种具有抗肿瘤,抗病毒,免疫调节等生物学功能的细胞因子,已经应用于医学研究和临床多种疾病的治疗。近年来,IFN-γ在抗肿瘤,抗感染和治疗自身免疫病方面有了更广泛的应用,然而也有报道称IFN-γ可以促进某些疾病的发生。因此分析总结IFN-γ在一些疾病中的作用机制及作用效果,对于临床应用具有重要的指导意义。 Interferon gamma(IFN-γ) ,belonging to type II interferon,is a kind of cytokine with antitu- mot, antiviral,immune regulatory as well as other biological effects. IFN-γ has been applied to medical research and clinical treatment for various diseases. In recent years, IFN-γ has wide applications in antitumor, anti-infec- tion and the treatment of autoimmune diseases. However,it has also been reported that IFN-γ may promote the oecurance of certain diseases. Therefore, we summarized the recent reports and expectation of IFN-γ in the clinical application.
作者 盖睛 单风平
出处 《国际免疫学杂志》 CAS 2015年第1期58-63,共6页 International Journal of Immunology
基金 辽宁省社会发展基金(2009225008-7 2012225016)
关键词 干扰素Γ 抗肿瘤 免疫调节 临床应用 Interferon gamma-γ Antitumor Immune regulation Clinical application
  • 相关文献

参考文献3

二级参考文献88

  • 1[1]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52
  • 2[2]Afdhal NH.The natural history of hepatitis C.Semin Liver Dis 2004; 24 Suppl 2:3-8
  • 3[3]Manns MP,McHutchison JG,Gordon SC,Rustgi VK,Shiffman M,Reindollar R,Goodman ZD,Koury K,Ling M,Albrecht JK.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomised trial.Lancet 2001; 358:958-965
  • 4[4]Fried MW,Shiffman ML,Reddy KR,Smith C,Marinos G,Goncales FL Jr,Haussinger D,Diago M,Carosi G,Dhumeaux D,Craxi A,Lin A,Hoffman J,Yu J.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.N Engl J Med 2002; 347:975-982
  • 5[5]Guidotti LG,Chisari FV.Immunobiology and pathogenesis of viral hepatitis.Annu Rev Pathol 2006; 1:23-61
  • 6[6]Lechner F,Wong DK,Dunbar PR,Chapman R,Chung RT,Dohrenwend P,Robbins G,Phillips R,Klenerman P,Walker BD.Analysis of successful immune responses in persons infected with hepatitis C virus.J Exp Med 2000; 191:1499-1512
  • 7[7]Thimme R,Oldach D,Chang KM,Steiger C,Ray SC,Chisari FV.Determinants of viral clearance and persistence during acute hepatitis C virus infection.J Exp Med 2001; 194:1395-1406
  • 8[8]Thimme R,Bukh J,Spangenberg HC,Wieland S,Pemberton J,Steiger C,Govindarajan S,Purcell RH,Chisari FV.Viral and immunological determinants of hepatitis C virus clearance,persistence,and disease.Proc Natl Acad Sci USA 2002; 99:15661-15668
  • 9[9]Bertoletti A,Maini MK,Protection or damage:a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Immunol 2000; 12:403-408
  • 10[10]Charo IF,Ransohoff RM.The many roles of chemokines and chemokine receptors in inflammation.N Engl J Med 2006; 354:610-621

共引文献20

同被引文献68

引证文献4

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部